Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?How many years does kadcyla's market exclusivity last?Patent expiry trametinib?Prolia and osteonecrosis?Generic brand for latisse?
See the DrugPatentWatch profile for Camzyos
Camzyos (mavacamten) in the United States: - FDA approval: April 28, 2022 - US launch: May 2022 If you’re asking about a different country or region, tell me which one and I’ll provide the specific launch date for that market.
Other Questions About Camzyos :